CENTRAL NERVOUS SYSTEM DISEASES

Brand Owner (click to sort) Address Description
CADUET C.P. PHARMACEUTICALS INTERNATIONAL C.V. 235 East 42nd Street New York NY 10017 CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, SLEEP DISORDERS, NEUROLOGICAL DISORDERS, UROLOGICAL DISORDERS, UROGENITAL DISORDERS, GASTROINTESTINAL DISORDERS, MUSCULOSKELETAL DISORDERS, ALLERGIES, DIABETES, HYPERTENSION, ERECTILE DYSFUNCTION, SEXUAL DYSFUNCTION, STROKE, CANCER, MIGRAINES, PAIN, OBESITY, INFLAMMATION, INFLAMMATORY DISEASES, RESPIRATORY DISEASES, INFECTIOUS DISEASES, NAMELY, CHOLESTEROL PREPARATIONS, SMOKING CESSATION PREPARATIONS, DERMATOLOGICAL PREPARATIONS, GYNECOLOGICAL PREPARATIONS, OSTEOPOROSIS PREPARATIONS, OPHTHALMOLOGICAL PREPARATIONS;PRINTED MATERIALS, NAMELY, MANUALS, BOOKLETS, PAMPHLETS, NEWSLETTERS, LEAFLETS, CHARTS, CATALOGS, DISPLAYS AND POSTERS ON THE TOPIC OF CHOLESTEROL MANAGEMENT,HYPERTENSION AND THE TREATMENT OF CARDIOVASCULAR DISORDERS;MEDICAL INFORMATION SERVICES, NAMELY, PROVIDING HEALTH INFORMATION IN THE FIELD OF CHOLESTEROL MANAGEMENT,HYPERTENSION AND THE TREATMENT OF CARDIOVASCULAR DISORDER;
OPOVAS C.P. PHARMACEUTICALS INTERNATIONAL C.V. 235 East 42nd Street New York NY 10017 central nervous system diseases and disorders, sleep disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations;
OPOVASC C.P. PHARMACEUTICALS INTERNATIONAL C.V. 235 East 42nd Street New York NY 10017 central nervous system diseases and disorders, sleep disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. This invention relates to novel diazabicyclic biaryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.